Surrozen (SRZNW) Stock Analysis

What Surrozen does

Surrozen, Inc. is a biotechnology company dedicated to identifying and advancing therapeutic candidates. Their core strategy involves precisely influencing the Wnt signaling pathway to promote the body's natural processes of tissue restoration and regeneration. To achieve this, Surrozen engineers antibodies that target specific tissues, aiming to activate the intrinsic repair systems of the body. These innovative therapies hold promise for a wide range of medical conditions affecting organs such as the intestine, liver, eyes (retina, cornea), lungs, kidneys, inner ear (cochlea), skin, pancreas, and the central nervous system. Among its pipeline assets, SZN-043 is designed to foster the regeneration of liver cells (hepatocytes), thereby enhancing liver function and mitigating fibrosis. Additionally, SZN-1326 is a novel bi-specific human antibody. This agent specifically interacts with Frizzled and LRP receptors, which are abundantly found in intestinal crypts, to directly regulate Wnt signaling within the target intestinal tissue. Established in 2016, Surrozen, Inc. operates from its headquarters in South San Francisco, California.

Key metrics

ETFs linked to SRZNW

Broad-market and Healthcare sector ETFs an investor holding Surrozen is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SRZNW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Surrozen?

Surrozen trades under the ticker SRZNW on NASDAQ.

Which exchange is SRZNW listed on?

SRZNW is listed on NASDAQ.

What sector does Surrozen operate in?

Surrozen is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SRZNW in a portfolio?

PortView shows SRZNW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.